Teva Announces Launch of its Generic Version of Canasa (mesalamine) Suppositories To Treat Adults with Active Ulcerative Proctitis (ulcerative rectal colitis), in the United States - Seite 4
1 CANASA and its design are trademarks of Aptalis Pharma Canada ULC, an AbbVie company.
2 https://emedicine.medscape.com/article/179037-overview
3 https://emedicine.medscape.com/article/183084-overview#a6
4 https://emedicine.medscape.com/article/183084-overview#a6
Lesen Sie auch
View source version on businesswire.com: https://www.businesswire.com/news/home/20210423005422/en/
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte